XML 42 R12.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stock-Based Compensation
3 Months Ended
Sep. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
4. Stock-Based Compensation
 
Stock options are granted with exercise prices not less than the fair market value of our common stock at the time of the grant, with an exercise term (as determined by the committee administering the applicable option plan (the “Committee”)) not to exceed 10 years. The Committee determines the vesting period for the Company’s stock options. Generally, such stock options have vesting periods of immediate to four years. Certain option awards provide for accelerated vesting upon meeting specific retirement, death or disability criteria and upon a change in control. During the three month periods ended September 30, 2015 and 2014, the Company granted options to purchase 230,000 and 277,000 shares of the Company’s common stock, respectively.
 
Stock-based compensation expense for the three month periods ended September 30, 2015 and 2014 was approximately $301,000 and $214,000, respectively. Compensation expense is recognized in the general and administrative expenses line item of the Company’s consolidated statements of operations on a straight-line basis over the vesting periods. As of September 30, 2015, there was approximately $3,795,000 of total unrecognized compensation cost related to non-vested stock-based compensation arrangements to be recognized over a weighted-average period of 3.0 years.
 
Cash in the amount of $136,056 was received from the exercise of stock options for the three months ended September 30, 2015. Total options exercised, by either cash or through surrender of previously owned shares, were 19,789. There were no options forfeited, expired or acquired in any other method for the three months ended September 30, 2015.
 
The fair values of the options granted during the three months ended September 30, 2015 and 2014 were primarily estimated on the date of the grant using the Black-Scholes option-pricing model on the basis of the following weighted average assumptions during the respective periods:
 
 
 
For the three months ended
 
 
 
September 30,
 
 
 
2015
 
 
2014
 
Risk-free interest rate
 
 
1.48
%
 
 
1.32
%
Expected option life in years
 
 
5.0
 
 
 
6.5
 
Expected stock price volatility
 
 
60.04
%
 
 
75.0
%
Expected dividend yield
 
 
0
%
 
 
0
%
Weighted-average fair value of options granted
 
$
4.73
 
 
$
5.95
 
 
The expected option term is based upon the number of years the Company estimates the option will be outstanding based on historical exercises and terminations. The expected volatility for the expected life of the options is determined using historical price changes of the Company’s stock over a period equal to that of the expected life of the options. The risk free rate is based upon the U.S. Treasury yield in effect at the time of the grant. The expected dividend yield is 0% as the Company has historically not declared dividends and does not anticipate declaring any in the future.
 
Changes in outstanding stock options during the three months ended September 30, 2015 were as follows:
 
 
 
Options
 
 
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
 
 
 
 
 
Average
 
 
 
 
 
 
 
 
 
Weighted
 
Remaining
 
 
 
 
 
 
 
 
 
Average
 
Contractual
 
Aggregate
 
 
 
Number of
 
Exercise
 
Life
 
Intrinsic
 
 
 
Shares
 
Price ($)
 
(years)
 
Value (a)
 
Outstanding as of June 30, 2015
 
 
1,557,616
 
 
5.80
 
 
 
 
 
 
 
Granted
 
 
230,000
 
 
9.43
 
 
 
 
 
 
 
Exercised
 
 
(23,387)
 
 
7.44
 
 
 
 
$
89,710
 
Forfeited
 
 
-
 
 
 
 
 
 
 
 
 
 
Expired
 
 
-
 
 
 
 
 
 
 
 
 
 
Outstanding as of September 30, 2015
 
 
1,764,229
 
 
6.25
 
 
7.2
 
$
8,376,193
 
Exercisable and vested at September 30, 2015
 
 
822,154
 
 
3.48
 
 
6.2
 
$
5,956,818
 
Available for grant as of September 30, 2015
 
 
569,600
 
 
 
 
 
 
 
 
 
 
 
(a)
Intrinsic value for purposes of this table represents the amount by which the fair value of the underlying stock, based on the respective market prices at September 30, 2015 or if exercised, the exercise dates, exceeds the exercise prices of the respective options.